CureSight Idivayisi Yokwelapha Iso Elivilaphayo ngu-Kobi Kor

Umdwebo CureSight Idivayisi Yokwelapha Iso Elivilaphayo ngu-Kobi Kor ungumnqobi ohlonishwa kakhulu womklomelo odumile we-2022 Umklomelo Wensimbi we-A' Design Award Esigabeni Somncintiswano se-Umkhiqizo Wezokwelapha.

InsimbiUmkhiqizo Wezokwelapha· 2022

CureSight Idivayisi Yokwelapha Iso Elivilaphayo

ngu Kobi Kor

Iklayenti: Novasight

Umnqobi we-Umklomelo Wensimbi we-A' Design Award Esigabeni se-Umkhiqizo Wezokwelapha

22,237

Umnqobi Womklomelo Oqinisekisiwe

Qinisekisa Isimo Somklomelo se-#133911

Thola Manje Vakashela Isayithi Buka ku-A' Design Award Isitatimende Sabezindaba Ibheji Yomklomelo

Imibala

Ukuklama

Mayelana ne-CureSight Idivayisi Yokwelapha Iso Elivilaphayo

Inqubo yokuklama ye-CureSight igxile ekudaleni umkhiqizo kanye nesixazululo sokwelashwa esizokwenza umthelela omuhle emphakathini futhi isize iziguli, iningi lazo okungabantwana, ukugwema ukungakhululeki kanye nokuphoxeka okuhilelekile ekwelashweni kwendabuko nge-patch yamehlo. Idizayini iphinde igcizelele ukuthi ukubukeka nomuzwa womkhiqizo kubalulekile ekukhuthazeni nasekunikeni amandla izingane. Ugqozi lwedizayini yesitayela luvela kumagajethi obuchwepheshe izingane ezithanda ukuwasebenzisa nokudlala ngawo. Idizayini yomumo inikeza ukubukeka okushelelayo nesimanje komkhiqizo wensiza yezokwelapha.

Ukuqashelwa

Mayelana ne-Umklomelo Wensimbi we-A' Design Award

CureSight Idivayisi Yokwelapha Iso Elivilaphayo iwinile uMklomelo Wensimbi we-A' Design Award, ukwaziswa okuhloniphekile okunikezwa imiklamo emihle ehlangabezana nezidingo zobungcweti nezemboni ezilindelekile ezimpahleni ezihlelwe kahle. Abawinile beNsimbi babonisa ikhono elikhulu, ubungcweti obuphezulu, ukuqonda kochwepheshe namandla okudala abadali babo. CureSight Idivayisi Yokwelapha Iso Elivilaphayo ilindeleke ukuba ibe yinto exatshwa kakhulu, edunyiswayo nethandwayo esebenzayo nenezinto ezintsha. Lo mklamo owinile uMklomelo Wensimbi we-A' Design Award uhlanganisa izindlela ezinhle kakhulu zemboni futhi unezimfanelo zobuchwepheshe ezifanelekile ezihlanganiswe nolwazi nethalente. CureSight Idivayisi Yokwelapha Iso Elivilaphayo iyahlonishwa ngenxa yokucophelela kwayo futhi ihlelelwe ukulethela izinguquko zomgangatho wempilo ezisiza ukwenza umhlaba ube yindawo engcono.

Ngemuva Kokuklama

Iphakheji Yabezindaba

Ama-credit, amalungu eqembu nemininingwane yobuchwepheshe ehlinzekwe ngumklami.

Izici Ezihlukile: The curesight is a powerful solution with great potential to totally change the treatment of lazy eye condition, with the important advantage of treating the lazy eye from the comfort of home and by watching any tv or streaming video content.
This healthcare solution for lazy eye condition integrates high-end technologies for eye-tracking and ai software tools for smart analyzing of the lazy eye condition and providing personal custom treatment. The gold standard care for lazy eye is placing a patch over the strong eye, an old-fashioned solution that suffers from very low compliance.
Izilinganiso Nokupakisha: product net dimensions
Height 230mm
Width 390mm
Depth 60mm
Amathegi: amlyopia, lazy eye, medical device, product design, social impact, degital healthcare
Ubuchwepheshe Bokukhiqiza: The design activity started with a brainstorming meeting to learn more about the problem from the clinical and user needs aspects, and to outline the main big limitations of today's treatment methods.
We also discussed the ergonomics and usability needs to be able to provide the best treatment.
during the design process, we tested several design concepts both aesthetically and with physical mockups,
Production technologies include aluminum CNC machining and anodize plating, for the front bezel and plastic injection for the back cover and small covers.
Inselele Yokudweba: The creative challenge was to dress the unique technology components with style and to provide a good user experience to the users, the specific usability needs to enable good treatment for various populations and make it an appealing and empowering treatment device, and lead to important social impact
Ucwaningo: Following an intense effort over the last 18 months, the company officially announced that the company successfully met the primary endpoint of the CureSight randomized, controlled pivotal trial of amblyopia treatment against the gold standard patching.
This is the first-ever pivotal study in which a digital device was shown to be non-inferior to eye patching for amblyopia treatment in children.
The study also exhibited 93% adherence to the curesight treatment, as well as a 93% likelihood of the parents choosing curesight over patching.
Ugqozi: The inspiration for the curesight product started from a personal experience when one of my kids needed to treat the lazy eye condition with the eye patch solution, I learned from this experience about the discomfort of wearing the eye patch for a few hours every day and especially how embarrassing it is from the social point of view.
The inspiration for the styling design came from the tech gadgets that kids love to use and play with, to provide a slick and modern design to a medical device product type, the front aluminum bezel, and the back swallowtail gives the product a clean gadget look.
Ubude Bephrojekthi: The project started in 2019 in Tel Aviv, and finished in late 2021, the project was exhibited at the CES in January 2020 in Las Vegas
Ukuhamba Kokusebenza: The patient, most likely kids will have the fun be treated by the Curesight while watching any video content they love to watch without any degradation in quality and from the comfort of home.
Amalungu Eqembu: Kobi Kor
Tal Samet
Amakhredithi Ezithombe: All images
Photograph and Illustrations: Novasight and Kobi Kor